Stratagen Bio

Stratagen Bio is a healthcare company in Cambridge, United States, founded in 2019. It has raised $5.0M across 1 round, most recently a $5.0M Seed in June 2026.

The Future of MRI

Employees
1–10
Founded
2019
Business Model
B2B
Total Funding
$5.0M
Last Round
$5.0M SeedJun 2026
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

Stratagen Bio is a Harvard-based life sciences company transforming MRI into a platform for quantitative biomarker assessment and objective clinical decision-making. Founded by Gregory Ekchian (CEO) and Professor Michael Cima, the company enhances existing MRI hardware to yield precise quantitative tissue measurements enabling more in-depth, objective data on tissue health without requiring new scanner infrastructure. The approach is especially valuable for detecting and treating cancer, neurological conditions, and muscular pathologies. Stratagen Bio is a resident of the Pagliuca Harvard Life Lab and was a Grand Prize winner of the 2024 Harvard President's Innovation Challenge.

Summary

It lists 1–10 employees. It has raised $5.0M in total across 1 round, most recently a $5.0M Seed round in Jun 2026. Investors include Critical Venture Partners.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
SeedSeed RoundJun 2026
$5.0M

Investors

Similar Companies

Neko Health

Neko Health delivers preventive health scans that combine skin, heart, blood, and body measuremen...

Stockholm, Sweden201–500Artificial Intelligence, Digital Health
Series CTotal funding$1.1BJul 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
PHC

PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...

Minato, Japan5001–10000Healthcare, Life Sciences
Private EquityTotal funding$1.9BMar 2021

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Stratagen Bio on Indexed.vc
<a href="https://indexed.vc/companies/stratagen-bio"><img src="https://indexed.vc/api/badge/company/stratagen-bio" alt="Stratagen Bio on Indexed.vc" width="260" height="76" /></a>